• Bookmark and Share
  • Printer Friendly
  • Text Resizer - Small
  • Text Resizer - Large
  • Email this page

Antihypertensives Antihypertensives

Browse our health professional information, resources and educational activities on antihypertensives.

QUM rationale

Drug therapy is the mainstay of treatment in hypertension. Quality use of antihypertensives focuses on ensuring hypertension is managed in the context of all modifiable cardiovascular risk factors.

Presence of co-morbidities should guide selection of antihypertensives. Thoughtful selection of an antihypertensive drug with favourable effects on existing co-morbidities can maximise the benefits of therapy (e.g. ACE inhibitors or angiotensin II-receptor antagonists in diabetes nephropathy), and careful avoidance of an agent with unfavourable effects on existing co-morbidities can minimise harm from therapy (e.g. beta blockers in severe bradycardia). Beta blockers remain under-used in patients with co-morbidities of coronary heart disease or heart failure. In the absence of co-morbidities, low-dose thiazide diuretics have consistent and substantive cardiovascular outcome evidence and remain a good first choice for most patients with uncomplicated hypertension.

Effective use of antihypertensives requires frequent monitoring to achieve target blood pressure, and for most patients, this involves multiple drug therapy. Good communication between the health professional and the patient is required to achieve adherence with therapy.

Key messages from 2007 therapeutic program

  • Assess absolute cardiovascular risk and manage hypertension along with other modifiable risk factors
    • use a cardiovascular risk calculator in primary prevention
  • When selecting antihypertensive drugs, consider potentially favourable effects on coexisting conditions
    • low-dose thiazides have strong clinical outcome evidence for most populations
    • use beta blockers in people with cardiac disease (heart failure, post-MI, angina)
    • use ACE inhibitors or angiotensin II-receptor antagonists in diabetic nephropathy
  • If using a fixed-dose combination product, choose according to the drug components and the dose range available
    • most people require two or more antihypertensive drugs
  • Assess adherence with medication and lifestyle changes at every opportunity and intervene if necessary.

Resources

Resource Date* Title
Activity - Case Study 2007-06-01 00:00:00 Case study 48: Achieving tight blood pressure control
Activity - Case Study 2003-08-01 00:00:00 Case study 28: Managing hypertension in diabetes
Activity - Case Study 1999-10-01 00:00:00 Case study PH1: For pharmacists
Activity - Case Study Report 2007-07-01 00:00:00 Achieving tight blood pressure control
Activity - Case Study Report 2003-10-01 00:00:00 Case study 28 report: Managing hypertension in diabetes
Activity - Case Study Report 2000-06-01 00:00:00 Case study PH1 report: For pharmacists
Activity - Case Study Report 2000-01-01 00:00:00 Case study 6 report: Management of hypertension
Factsheet - Health Professional 2004-06-01 00:00:00 Guide to selecting antihypertensive drugs in patients with co-existing conditions
NPS News - Health Professional Publication 2007-06-01 00:00:00 NPS News 52: Managing hypertension as a cardiovascular risk factor
NPS News - Health Professional Publication 2003-08-01 00:00:00 NPS News 29: Hypertension management to reduce cardiovascular risk
NPS News - Health Professional Publication 1999-10-01 00:00:00 NPS News 6: Diagnosis and treatment of hypertension
NPS RADAR>Brief Item>Health Professional Publication 2008-08-01 00:00:00 Lercanidipine with enalapril (Zan-Extra) fixed-dose combination tablets PBS listed for hypertension
NPS RADAR>Brief Item>Health Professional Publication 2007-08-01 00:00:00 Perindopril arginine with indapamide hemihydrate (Coversyl Plus)
NPS RADAR>Brief Item>Health Professional Publication 2007-08-01 00:00:00 Be aware of dose ranges for new ramipril with felodipine combination (Triasyn) (see erratum below)
NPS RADAR>Brief Item>Health Professional Publication 2007-04-01 00:00:00 Trandolapril 4 mg with verapamil sustained-release 240 mg fixed-dose combination tablet (Tarka) to be listed on PBS
NPS RADAR>Brief Item>Health Professional Publication 2006-08-01 00:00:00 Change of perindopril (Coversyl) salt from erbumine to arginine
NPS RADAR>Review>Health Professional Publication 2007-08-01 00:00:00 Olmesartan medoxomil (Olmetec) monotherapy or in combination with hydrochlorothiazide (Olmetec Plus) for hypertension
NPS RADAR>Review>Health Professional Publication 2006-12-01 00:00:00 Amlodipine with atorvastatin (Caduet) for dyslipidaemia with concomitant hypertension or angina
NPS RADAR>Review>Health Professional Publication 2006-08-01 00:00:00 Moxonidine (Physiotens) for hypertension
NPS RADAR>Review>Health Professional Publication 2005-08-01 00:00:00 Angiotensin II receptor antagonists: unrestricted PBS listing
NPS RADAR>Review>Health Professional Publication 2003-11-01 00:00:00 Ramipril (Tritace) titration pack
NPS RADAR>Review>Health Professional Publication 2003-01-01 00:00:00 Who's right about thiazides: ALLHAT or ANBP2?
NPS RADAR>Web Only Item>Health Professional Publication 2007-08-01 00:00:00 Additional content: Olmesartan medoxomil monotherapy or in combination with hydrochlorothiazide for hypertension
Prescribing Practice Review - Health Professional Publication 2007-07-01 00:00:00 NPS Prescribing Practice Review 38: Managing hypertension as a cardiovascular risk factor
Prescribing Practice Review - Health Professional Publication 2003-10-07 00:00:00 NPS Prescribing Practice Review 23: Managing hypertension
Prescribing Practice Review - Health Professional Publication 2001-09-10 00:00:00 NPS Prescribing Practice Review 13: Management of hypertension: an update
Tool - Health Professional 2009-03-12 00:00:00 Cardiovascular risk calculator

* Information current at date of publication.

Useful information from Australian Prescriber

Content type
Date*
Title
Australian Prescriber - ArticleFebruary 2007Should beta blockers remain first-line drugs for hypertension?
Australian Prescriber - ArticleApril 2005First-line medicines in the treatment of hypertension
Australian Prescriber - ArticleAugust 2004Resolving the differences between ACE inhibitors and diuretics: ALLHAT and ANBP2
Australian Prescriber - ArticleJune 2003Hypertension: how low to go?
Australian Prescriber - ArticleFebruary 2002Hypertension in diabetes
Australian Prescriber - ArticleOctober 2001Facilitators file: combination antihypertensives
Australian Prescriber - ArticleOctober 1999Is there a place for thiazide diuretics in the management of hypertension?
Australian Prescriber - ArticleOctober 1998Angiotensin receptor antagonists for the treatment of hypertension
Australian Prescriber - Editorial April 1994 Australian consensus conference on the management of hypertension
Australian Prescriber - EditorialFebruary 1999Calcium channel blockers: the continuing controversy
Australian Prescriber - Diagnostic tests February 1997 24-hour blood pressure monitoring: what are the benefits

* Information current at date of publication.

This site complies to the HONcode standard for trustworthy health information: verify here.
Health Insite Logo This website is certified by Health On the Net Foundation. Click to verify.